Skip to main content
. 2014 Mar 28;171(8):1973–1987. doi: 10.1111/bph.12431

Figure 4.

Figure 4

BH3 mimetics (2). (A) BCL-XL and BCL-2 inhibitor derived from ABT-737; (B) BCL-XL and BCL-2 inhibitor BM-957; (C) BCL-XL and BCL-2 inhibitor; (D) selective BCL-2 inhibitor ABT-199; (E) selective BCL-XL inhibitor WEHI-539; (F) selective MCL-1 inhibitor MIM-1; (G) selective MCL-1 inhibitor.